Welcome to the Oncomine Blog
Evaluating NGS technologies for in-house comprehensive genomic profiling
11/13/2024 |
Research
In everyday practice, it is common for pathology labs to evaluate >50% cytological specimens across solid tumors especially in lung and pancreatic...
-
Biomarker Tests for Precision Oncology: DIY or Pay-for-Service?
Cancer patient management of is increasingly driven by biomarker assays – but how should we manage t... -
Evaluating the Oncomine Myeloid Assay GX for Detection of Key Variants
Dr. Yi Ding of Geisinger Medical Laboratories recently presented at the 2020 Association of Molecula... -
What is Comprehensive Genomic Profiling & is it the Right Solution for You?
What is comprehensive genomic profiling? Comprehensive genomic profiling, or CGP, is the simultaneou...